| David J Eschler, PA-C | |
|
14520 W Granite Valley Dr Ste 210, Sun City West, AZ 85375-5855 | |
| (866) 974-2673 | |
| (866) 939-2673 |
| Full Name | David J Eschler |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 14520 W Granite Valley Dr Ste 210, Sun City West, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255770863 | NPI | - | NPPES |
| PA22993 | Other | CA | CA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | PA22993 (California) | Secondary |
| 363A00000X | Physician Assistant | 6022 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Core Institute Specialty Hospital, The | Phoenix, AZ | Hospital |
| Banner Del E. Webb Medical Center | Sun city west, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Orthopedic Research And Education Llc | 0345287322 | 236 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops antibody-based anticancer products using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's IMGN388 anticancer compound at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany.
Premiums for employer-sponsored family health insurance increased by 50 percent from 2003 to 2010, and the annual amount that employees pay toward their insurance increased by 63 percent as businesses required employees to contribute a greater share, according to a new Commonwealth Fund report that examines state trends in health insurance costs.
A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.
Researchers from Ludwig-Maximilians-Universitaet in Munich have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory Syndrome. Planning for the first clinical trial is now underway.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David J Eschler, PA-C 18444 N 25th Ave, Suite 310, Phoenix, AZ 85023-1261 Ph: (866) 974-2673 | David J Eschler, PA-C 14520 W Granite Valley Dr Ste 210, Sun City West, AZ 85375-5855 Ph: (866) 974-2673 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops antibody-based anticancer products using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's IMGN388 anticancer compound at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany.
Premiums for employer-sponsored family health insurance increased by 50 percent from 2003 to 2010, and the annual amount that employees pay toward their insurance increased by 63 percent as businesses required employees to contribute a greater share, according to a new Commonwealth Fund report that examines state trends in health insurance costs.
A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.
Researchers from Ludwig-Maximilians-Universitaet in Munich have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory Syndrome. Planning for the first clinical trial is now underway.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
› Verified 2 days ago
Linsy Angela Townsend, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 623-524-4000 | |
Patrick Landon Burrup, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 14502 Meeker Blvd, Sun City West, AZ 85375 Phone: 623-214-4000 Fax: 623-975-8752 | |
Bradford Gibson Tenney, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 14520 W Granite Valley Dr, Suite 210, Sun City West, AZ 85375 Phone: 623-537-5600 Fax: 866-939-2673 | |
Miss Tasha Grissett, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 623-524-8767 | |
Jason Muesch, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 623-524-4000 | |
Benito B Rodriguez, PA C Physician Assistant Medicare: Medicare Enrolled Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 623-214-4000 Fax: 623-214-4000 | |
Stephanie Verrell, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 14502 W Meeker Blvd, Banner Del E. Webb Emergency Dept, Sun City West, AZ 85375 Phone: 623-524-4067 |